ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.51
+0.14 (2.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
ENDRA Life Sciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
2.96M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Regional Health Properties | 15.75M |
| iSpecimen | 10.39M |
| LogicMark | 10.08M |
| SCWorx | 3.22M |
| Catheter Precision | 399.00K |
NDRA News
- 4 weeks ago - ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire
- 5 weeks ago - ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
- 5 weeks ago - Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024 - Business Wire
- 6 weeks ago - ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent - Business Wire
- 2 months ago - ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany - Business Wire
- 4 months ago - Data I/O And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
- 4 months ago - ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements - Business Wire
- 4 months ago - ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript - Seeking Alpha